Based on the highly successful virtual career fair held earlier this year for the chemical industry, the Sociéte de Chimie Industrielle will offer its Virtual Life Sciences Career Fair and Forum on November 19.
The virtual career fair will bring students and recent graduates from 50 of the highest ranked undergraduate and graduate schools together with pharmaceutical and life sciences organization. After a one-hour panel on valuable career-related issues, the remaining 90 minutes will be devoted to the career fair where students can meet with representatives from those sponsoring companies and organizations.
The event is currently being promoted via the department heads and career services units of each school, which includes California Institute of Technology; Cornell, University of California, San Francisco; University of California San Diego; NYU; MIT; Princeton, Cold Spring Harbor; Univ. of California Davis; Baylor College; Columbia; University of California, Los Angeles; and Yale University.
Students will sign up via a section of the Sociéte website by filling out a registration form and submitting their resume. The resumes are then distributed in advance to sponsoring pharmaceutical companies.
The virtual career fair will be held in a virtual “ballroom” where the students can privately visit each of the companies, ask questions, and interact with company representatives through the platform.
Benefits of joining this event as a pharmaceutical sponsor, include meeting students and graduates from a large pool of first-class candidates without travel; an electronic listing and description in the event program, and one or more dedicated tables during the virtual career fair. Sponsoring organizations will also have the opportunity to post a YouTube video recording where you can pitch the opportunities at your company, which will be available to the students who have registered on the Sociéte website.
The Sociéte de Chimie Industrielle (Sociéte) www.societe.org, founded 102 years ago, is a leading independent non-profit industry organization serving the chemical and life science industries that is involved in numerous educational activities including research scholarship grants, mentoring, networking events and more.
To find out more about this event and sponsorship, please contact Peter Young, President of Sociéte at pyoung@youngandpartners.com or Bob Kenworthy, V.P. of Administration at Sociéte, at kenworthy@comcast.net. The spring event featured over 150 students, from 25 schools and 10 companies. The companies reported making job offers to at least one student each, and very much enjoyed the format of the event.
https://www.societe.org/content.aspx?page_id=4002&club_id=11039&item_id=1480452
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
October 25th 2024Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.